A Qualitative Progression in HIV Type 1 Glycoprotein 120-Specific Cytotoxic Cellular and Humoral Immune Responses in Mice Receiving a DNA-Based Glycoprotein 120 Vaccine

AIDS Research and Human Retroviruses

Volumn 10, Issue 11, 1994, Pages 1433-1441

  Fuller, Deborah Heydenburg ^a   Haynes, Joel R ^a  

^a University Green ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GAMMA INTERFERON; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN G; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AIDS VACCINES; ANIMAL; CYTOTOXICITY, IMMUNOLOGIC; DNA, VIRAL; GENE PRODUCTS, ENV; GENETIC VECTORS; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP160; HIV-1; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; PROTEIN PRECURSORS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC;

EID: 0028170748     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.1994.10.1433     Document Type: Article

References (45)

1. Langlois AJ, Weinhold KJ, Matthews TJ, Greenberg ML, and Bolognesi DP: Detection of anti-human cell antibodies in sera from macaques immunized with whole inactivated virus. AIDS Res Hum Retroviruses 1992; 8: 1641–1652.
2. Langlois AJ, Weinhold KJ, Matthews TJ, Greenberg ML, and Bolognesi DP: The ability of certain SIV vaccines to provoke reactions against normal cells. Science 1992; 255: 292–293.
3. Cranage MP, Polyanskaya N, McBride B, Cook N, Ashworth LAE, Dennis M, Baskerville A, Greenaway PJ, Corcoran T, Kitchin P, Rose J, Murphey-Corb M, Desrosiers RC, Stott EJ, and Farrar GH: Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Res Hum Retroviruses 1993; 9: 13–22.
4. Hu S-L, Abrams K, Barber GN, Moran P, Zarling JM, Langlois AJ, Kuller L, Morton WR, and Benveniste RE: Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gpl60. Science 1992, 255: 456–459.
5. Fultz PN, Nara P, Barre-Sinoussi F, Chaput A, Greenberg ML, Muchmore E, Kieny M-P, and Girard M: Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science 1992; 256: 1687–1690.
6. Berman PW, Gregory TJ, Riddle L, Nakamura GR, Champe MA, Porter JP, Wurm FM, Hershberg RD, Cobb EK, and Eichberg JW: Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gpl20 but not gpl60. 0. Nature (London) 1990; 345: 622–625.
7. Shafferman A, Lewis MG, McCutchan FE, Benveniste RE, Jahrling PB, Burke DS, and Eddy GA: Prevention of transmission of simian immunodeficiency virus from vaccinated macaques that developed transient virus infection following challenge. Vaccine 1993; 11: 848–852.
8. Marx PA, Compans RW, Gettie A, Staas JK, Giley RM, Mulligan MJ, Yamshchikov GV, Chen D, and Eldridge JH: Protection against vaginal SIV transmission with microencapsulated vaccine. Science 1993; 260: 1323–1327.
9. Luke W, Voss G, Stahl-Hennig C, Coulibaly C, Putkonen P, Petry H, and Hunsmann G: Protection of cynomolgus macaques (Macaca fascicularis) against infection with the human immunodeficiency virus type 2 strain ben (HIV-2ben) by immunization with the virion-derived envelope glycoprotein gpl30. AIDS Res Hum Retroviruses 1993; 9: 387–394.
10. Stahl-Hennig C, Voss G, Dittmer U, Coulibaly C, Petry H, Makoschey B, Cranage MP, Aubertin AM, Luke W, and Hunsmann G: Protection of monkeys by a split vaccine against SIV mac depends upon biological properties of the challenge virus. AIDS 1993; 7: 787–795.
11. Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, and Desrosiers RC: Protective effects of a live attenuated SIV vaccine with a deletion in the nefgene. Science 1992; 258: 1938–1941.
12. Eisenbraun MD, Fuller DH, and Haynes JR: Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol 1993; 12: 791–797.
13. Robinson HL, Hunt LA, and Webster RG: Protection against a lethal influenza virus challenge by immunization with a hemagglutinin-expressing plasmid DNA. A. Vaccine 1993; 11: 957–960.
14. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Feigner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A, Hawe LA, Leander KR, Marinez D, Perry HC, Shiver JW, Montgomery DL, and Liu MA: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259: 1745–1749.
15. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, and Robinson HL: DNA vaccines: Protective immunizations by parenterai, mucosal, and gene gun inoculations. Proc Nati Acad Sci USA 1993; 90: 11478–11482.
16. Wang B, Ugen KE, Srikantan V, Agadjanyan MG, Dang K, Refaeli Y, Sato AI, Boyer J, Williams WV, and Weiner DB: Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Nati Acad Sci USA 1993; 90: 4156–4160.
17. Cox GJM, Zamb TJ, and Babiuk LA: Bovine herpesvirus 1: Immune responses in mice and cattle injected with plasmid DNA. J Virol 1993; 67: 5664–5667.
18. Tang D-C, DeVit M, and Johnston SA: Genetic immunization is a simple method for eliciting an immune response. Nature (London) 1992; 356: 152–154.
19. Yankauckas MA, Morrow JE, Parker SE, Abai A, Rhodes GH, Dwarki VJ, and Gromkowski SH: Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene. DNA Cell Biol 1993; 12: 771–776.
20. Montgomery DL, Shiver JW, Leander KR, Perry HC, Friedman A, Martinez D, Ulmer JB, Donnelly JJ, and Liu MA: Heterologous and homologous protection against influenza A by DNA vaccination: Optimization of DNA vectors. DNA Cell Biol 1993; 12: 777–783.
21. Fynan EF, Robinson HL, and Webster RG: Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA Cell Biol 1993; 12: 785–789.
22. Wang B, Boyer J, Srikantan V, Coney L, Carrano R, Phan C, Merva M, Dang K, Agadjanan M, Gilbert L, Ugen K, Williams W, and Weiner DB: DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA Cell Biol 1993; 12: 799–805.
23. Watanabe A, Raz E, Kohsaka H, Tighe H, Baird SM, Kipps TJ, and Carson DA: Induction of antibodies to a kappa V region by gene immunization. J Immunol 1993; 151: 2871–2876.
24. Stingl G: Dendritic cells of the skin. Dermatol Clin 1990; 8: 673–679.
25. Stingl G, Tschachler E, Groh V, Wolff K, and Hauser C: The immune functions of epidermal cells. Immunol Ser 1989; 4: 3–72.
26. Bos JD and Kapsenberg ML: The skin immune system: Progress in cutaneous biology. Immunol Today 1993; 14: 75–78.
27. Hennighausen L and Fleckenstein B: Nuclear factor 1 interacts with five DNA elements in the promoter region of the human cytomegalovirus major immediate early gene. EMBO J 1986; 5: 1367–1371.
28. Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, and Gregory TJ: Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gpl20) expressed in Chinese hamster ovary cells. J Biol Chem 1990; 265: 10373–10382.
29. Yang N-S, Burkholder J, Roberts B, Martinell B, and McCabe D: In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Nati Acad Sci USA 1990; 87: 9568–9572.
30. Christou P, McCabe DE, Martinell BJ, and Swain WF: Soybean genetic engineering—commercial production of transgenic plants. Trends Biotech 1990; 8: 145–151.
31. Takahashi H, Cohen J, Hosmalin A, Cease KB, Houghten R, Cornette JL, DeLisi C, Moss B, Germain RN, and Berzofsky JA: An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gpl60 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc Nati Acad Sci USA 1988; 85: 3105–3109.
32. Trono D and Baltimore D: A human cell factor is essential for HIV-1 Rev action. EMBO J 1990; 9: 4155–160.
33. Romagnani S: Induction of TH1 and TH2 responses: A key role for the “natural” immune response? Immunol Today 1992; 13: 379–381.
34. Powrie F and Coffman RL: Cytokine regulation of T-cell function: Potential for therapeutic intervention. Trends Pharm Sci 1993; 14: 164–168.
35. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS, and Locksley RM: Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. J Exp Med 1990; 171: 115–127.
36. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, and Bloom BR: Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254: 279–282.
37. + T cells can be primed in vitro to produce IL-4. J Immunol 1992; 148: 1652–1656.
38. Clerici M and Shearer GM: A TH1—>TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14: 107–111.
39. Clerici M, Giorgi JV, Chou C-C, Gudeman VK, Zack JA, Gupta P, Ho H-N, Nishanian PG, Berzofsky JA, and Shearer GM: Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992; 165: 1012–1019.
40. Kelker HC, Seidlin M, Vogler M, and Valentine FT: Lymphocytes from some long-term seronegative heterosexual partners of HIV infected individuals proliferate in response to HIV antigens. AIDS Res Hum Retroviruses 1992; 8: 1355–1359.
41. Clerici M, Lucey DR, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP, Dolan MJ, Hendrix CW, Wolf SF, and Shearer GM: Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 1993; 262: 1721–1724.
42. Clerici M, Hakim FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA, and Shearer GM: Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993; 91: 759–765.
43. Kanagawa O, Vaupel BA, Gayama S, Koehler G, and Kopf M.: Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS). Science 1993; 262: 240–242.
44. Bretscher PA, Wei G, Menon JN, and Bielefeldt-Ohmann H: Establishment of stable, cell-mediated immunity that makes “susceptible” mice resistant to Leishmania major. Science 1992; 257: 539–542.
45. Raz E, Watanabe A, Baird SM, Eisenberg RA, Parr TB, Lotz M, Kipps TJ, and Carson DA: Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc Nati Acad Sci USA 1993; 90: 4523–4527.